Concepedia

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer

Sandra Ortiz‐Cuaran, Aurélie Swalduz, Jean‐Philippe Foy, Solène Marteau, Anne‐Pierre Morel, Frédérique Fauvet, Geneviève De Souza, Lucas Michon, Maxime Boussageon, Nicolas Gadot,

European Journal of Cancer · 2022 · 32 citations · 57 references

DOI

Concepts

References

57

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

, , +17

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text

, , +15

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

, , +14

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie, Pablo Tamayo, Jesse S. Boehm et al. · Nature · 2009 · 4.2K citations · Full text

, , +13

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Étienne Becht, Nicolás A. Giraldo, Laetitia Lacroix et al. · Genome biology · 2016 · 4K citations · Full text

, , +17